Skip to main content
. 2019 Jul 17;17(7):e05750. doi: 10.2903/j.efsa.2019.5750

Table C.1.

Summary of in vitro genotoxicity data evaluated in FGE.204

FL‐no Chemical Name Test System in vitro Test Object Concentrations of Substance and Test Conditions Result Reference Comments
07.101 4‐Methylpent‐3‐en‐2‐one Reverse mutation

Salmonella Typhimurium

TA98, TA100, TA102, TA1535 and TA1537

1.6–5,000 μg/platea Negative Williams (2009) Valid. Study design complies with current recommendations
156.25–5,000 μg/platea , b Negative
Micronucleus assay Human peripheral blood lymphocytes 600–981.4 μg/mLc Negative Stone (2011)

Valid

Complies with OECD Guideline 487

200–981.4 μg/mLd Negative
100–500 μg/mLd Negative
100–300 μg/mLe Negative
07.177 7‐methyl‐3‐octenone‐2 Reverse mutation

S. Typhimurium

TA102

1.6–5,000 μg/platea Negative Ballantyne (2011) Valid. Studies combined comply with current recommendations
51.2–5,000 μg/platea , b Negative

S. Typhimurium

TA98, TA100, TA1535, TA1537, and TA1538

15–5,000 μg/platea Negative Thompson (1996)  
Micronucleus assay Human peripheral Blood lymphocytes 5–15 μg/mLc Equivocal Lloyd (2009)

Valid

Testing strategies including FISH analyses for determination of potential clastogenicity or aneugenicity. The study complies with OECD Guideline 487

30–60 μg/mLd Equivocal
2–6 μg/mLe Positive
5.5–8 μg/mLe Positive Lloyd (2010)

FGE: Flavouring Group Evaluation; FL‐no: FLAVIS number; FLAVIS: Flavour Information System; OECD: Organisation for Economic Co‐operation and Development; FISH: Fluorescence in situ hybridisation.

a

With and without S9‐mix metabolic activation.

b

Assay modified with pre‐incubation in the presence of S9‐mix.

c

Without metabolic activation, 3 h treatment + 21 h recovery.

d

With metabolic activation, 3 h treatment + 21 h recovery.

e

Without metabolic activation, 24 h + 0 h recovery.

Validity of genotoxicity studies:

Valid.

Limited validity (e.g. if certain aspects are not in accordance with OECD Guidelines or current standards and/or limited documentation).

Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards inappropriate/not validated test system).

Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided, text not in a Community language).